Glucagon-like peptide-1 (GLP-1) receptor agonists have emerged as a valuable class of drugs in the management of type 2 diabetes mellitus. These agents mimic the actions of naturally occurring GLP-1, stimulating https://peptidences.com/peptide-expertise